Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-16-020668)

Filing Details

Accession Number:: 0001179110-16-020668
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-03-02 17:14:19
Reporting Period:: 2016-02-29

Filing Date:: 2016-03-02
Accepted Time:: 2016-03-02 17:14:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1800	Abbott Laboratories	ABT	Pharmaceutical Preparations (2834)	360698440

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1452290	J Michael Warmuth	100 Abbott Park Road Abbott Park IL 60064-6400	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares Without Par Value	Acquisiton	2016-02-29	24,033	$0.00	69,217	No	4	A	Direct
Common Shares Without Par Value	Disposition	2016-02-29	4,807	$39.52	64,410	No	4	F	Direct
Common Shares Without Par Value	Disposition	2016-02-29	2,799	$38.84	61,611	No	4	S	Direct
Common Shares Without Par Value	Disposition	2016-02-29	6,600	$38.85	55,011	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares Without Par Value	29,586	Indirect	By trust

Footnotes

Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.
Held in the Stefanie M. Warmuth Revocable Trust. The reporting person and his spouse are trustees of the trust. The trust is revocable by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities.